CTSO
Cytosorbents
$4.40
−$0.84 (−16.03%)Oct 29, 2026
Key metrics
The numbers that frame CTSO today
- Market cap
- $13.83M
- Gross margin
- 71.6%
- EV / Sales
- 1.0
- ROIC
- -33.9%
- Div yield
- 0%
- 52wk Low
- $2.84
- 52wk High
- $17.00
Growth
Revenue and earnings trend for CTSO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CTSO
Is Cytosorbents a good buy?
No. Cytosorbents has mixed quality and poor momentum. The setup is weak overall. Growth looks poor. That could put pressure on the long-term business case. We think Cytosorbents is selling at a very high price.
What is the market capitalization of CTSO?
Cytosorbents's market capitalization is $13.83M.
What is the 52-week high for CTSO stock?
The 52-week high for Cytosorbents is $17.00. The current close of $4.40 is 74.1% below that high.
What is the 52-week low for CTSO stock?
The 52-week low for Cytosorbents is $2.84. The current close of $4.40 is 54.9% above that low.
Does CTSO stock pay dividends?
Cytosorbents does not currently show a dividend per share in the company data.